Subject to change.
Subject to change.
Co-chair, AMA/CPT DMCC, Entrepreneur-in-Residence, DigitalDx Ventures, Member, CPT Editorial Panel
Richard brings 4 decades’ success in a) regulatory labeling b) coverage and payment and c) clinical adoption of, therapeutics and diagnostics. Interests include addressing product-, market-, or delivery system-specific inefficiencies and issues which burden payers and delay or skew patients’ access to the benefits of innovation, including regulations, coding, valuation, coverage, and payment.